Aptinyx Inc (OQ:APTX)

Business Focus: Biopharmaceuticals

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for APTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 30th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 28/20 Feb 26/20 Khanna Ashish Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 230,000  
Feb 28/20 Feb 26/20 Kidd Andrew Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 255,000  
Feb 28/20 Feb 26/20 Riedel Norbert G Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 625,000  
Feb 14/20 Jan 29/20 Adams Street Partners Llc Indirect Ownership Common Stock J - Other transaction 90,124  
Jan 23/20 Jan 22/20 Sherman Rachel E. Direct Ownership Common Stock P - Open market or private purchase 2,174 $4.79
Jan 16/20 Jan 16/20 Bain Capital Life Sciences Investors, LLC Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jan 16/20 Jan 14/20 Koppel Adam Indirect Ownership Common Stock P - Open market or private purchase 3,333,333 $3.00
Jan 14/20 Jan 10/20 Riedel Norbert G Indirect Ownership Common Stock P - Open market or private purchase 35,000 $3.00
Jan 14/20 Jan 10/20 Hombach Robert J. Direct Ownership Common Stock P - Open market or private purchase 50,000 $3.00
Jan 14/20 Jan 10/20 Gosebruch Henry O Indirect Ownership Common Stock, par value $0.01 P - Open market or private purchase 25,000 $3.00
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for APTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 30th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 28/20 Feb 26/20 Khanna Ashish Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 230,000  
Feb 28/20 Feb 26/20 Kidd Andrew Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 255,000  
Feb 28/20 Feb 26/20 Riedel Norbert G Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 625,000  
Feb 14/20 Jan 29/20 Adams Street Partners Llc Indirect Ownership Common Stock J - Other transaction 90,124  
Jan 23/20 Jan 22/20 Sherman Rachel E. Direct Ownership Common Stock P - Open market or private purchase 2,174 $4.79
Jan 16/20 Jan 16/20 Bain Capital Life Sciences Investors, LLC Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jan 16/20 Jan 14/20 Koppel Adam Indirect Ownership Common Stock P - Open market or private purchase 3,333,333 $3.00
Jan 14/20 Jan 10/20 Riedel Norbert G Indirect Ownership Common Stock P - Open market or private purchase 35,000 $3.00
Jan 14/20 Jan 10/20 Hombach Robert J. Direct Ownership Common Stock P - Open market or private purchase 50,000 $3.00
Jan 14/20 Jan 10/20 Gosebruch Henry O Indirect Ownership Common Stock, par value $0.01 P - Open market or private purchase 25,000 $3.00
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $APTX

Competitors

Competitors with Recent Insider Filings
ChemoCentryx (OQ:CCXI)
Apellis Pharmaceuticals (OQ:APLS)
Twist Bioscience (OQ:TWST)